IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
carepen vet spenalyf, dreifa 600 mg
vetcare ltd.* - benzylpenicillinprocainum - spenalyf, dreifa - 600 mg
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
carepen vet (caremast vet) spenalyf, dreifa 600 mg
vetcare oy - benzylpenicillinprocainum - spenalyf, dreifa - 600 mg
Europese Unie -
IJslands -
EMA (European Medicines Agency)
ravicti
immedica pharma ab - glýseról fenýlbútýrat - Þvagfærasýkingar, innfæddir - Önnur meltingarvegi og efnaskipti vörur, - ravicti er ætlað til að nota eins og venjulega meðferð fyrir langvarandi stjórnun sjúklinga með súrefnismettun hringrás vandamál (ucds) þar á meðal galla á karbamóýl fosfórinn-þétti-ég (suv), ornithine carbamoyltransferase (otc), argininosuccinate lígasa (rass), argininosuccinate lýasa (ys), arginase ég (rÖk) og ornithine translocase skort hyperornithinaemia-hyperammonaemia homocitrullinuria heilkenni (hhh) sem getur ekki verið stjórnað af mataræði prótín takmörkun og/eða amínósýruna viðbót einn. ravicti verður að nota með mataræði prótín takmörkun og í sumum tilfellum, fæðubótarefni (e. , nauðsynleg amínósýrur, arginín, sítrólín, próteinlaus viðbót við kaloría).
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
atropin viatris (atropin mylan) stungulyf, lausn 0,5 mg/ml
viatris limited - atropine sulfate - stungulyf, lausn - 0,5 mg/ml
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
efedrin mylan stungulyf, lausn 50 mg/ml
viatris limited - ephedrini chloridum - stungulyf, lausn - 50 mg/ml
Europese Unie -
IJslands -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
virofob (vinritis 245 mg filmuhúðuð tafla) filmuhúðuð tafla 245 mg
zentiva k.s.* - tenofovirum disoproxil súkkínat - filmuhúðuð tafla - 245 mg
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 12,5 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 12,5 mg
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 25 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 25 mg
IJsland -
IJslands -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 50 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 50 mg